Wells Fargo & Company Ptc Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 38,148 shares of PTCT stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,148
Previous 26,649 43.15%
Holding current value
$1.87 Million
Previous $988,000 74.29%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$34.99 - $52.07 $402,350 - $598,752
11,499 Added 43.15%
38,148 $1.72 Million
Q3 2024

Nov 13, 2024
SELL
$30.39 - $37.66 $127,273 - $157,720
-4,188 Reduced 13.58%
26,649 $988,000
Q2 2024

Aug 13, 2024
BUY
$24.69 - $40.12 $79,798 - $129,667
3,232 Added 11.71%
30,837 $942,000
Q1 2024

May 10, 2024
BUY
$24.15 - $31.95 $52,960 - $70,066
2,193 Added 8.63%
27,605 $803,000
Q4 2023

Feb 09, 2024
SELL
$18.07 - $29.37 $503,900 - $819,011
-27,886 Reduced 52.32%
25,412 $700,000
Q3 2023

Nov 13, 2023
SELL
$22.41 - $41.99 $225,086 - $421,747
-10,044 Reduced 15.86%
53,298 $1.19 Million
Q2 2023

Aug 15, 2023
BUY
$40.4 - $59.1 $946,814 - $1.39 Million
23,436 Added 58.73%
63,342 $2.58 Million
Q1 2023

May 12, 2023
BUY
$38.16 - $48.86 $1.48 Million - $1.89 Million
38,763 Added 3391.34%
39,906 $1.93 Million
Q4 2022

Feb 13, 2023
SELL
$33.53 - $54.79 $62,600 - $102,292
-1,867 Reduced 62.03%
1,143 $43,000
Q3 2022

Nov 14, 2022
SELL
$41.85 - $53.85 $34,107 - $43,887
-815 Reduced 21.31%
3,010 $151,000
Q2 2022

Aug 12, 2022
SELL
$25.6 - $45.23 $876,441 - $1.55 Million
-34,236 Reduced 89.95%
3,825 $154,000
Q1 2022

May 16, 2022
SELL
$33.33 - $44.6 $751,391 - $1.01 Million
-22,544 Reduced 37.2%
38,061 $1.42 Million
Q4 2021

Feb 14, 2022
BUY
$35.36 - $41.86 $105,867 - $125,328
2,994 Added 5.2%
60,605 $2.41 Million
Q3 2021

Nov 15, 2021
BUY
$37.01 - $44.74 $439,271 - $531,019
11,869 Added 25.95%
57,611 $2.14 Million
Q2 2021

Aug 16, 2021
SELL
$37.95 - $49.37 $851,560 - $1.11 Million
-22,439 Reduced 32.91%
45,742 $1.93 Million
Q1 2021

May 13, 2021
SELL
$46.8 - $68.92 $775,897 - $1.14 Million
-16,579 Reduced 19.56%
68,181 $3.23 Million
Q4 2020

Feb 09, 2021
BUY
$47.96 - $67.64 $893,638 - $1.26 Million
18,633 Added 28.18%
84,760 $5.17 Million
Q3 2020

Nov 05, 2020
SELL
$45.41 - $57.07 $4.66 Million - $5.85 Million
-102,531 Reduced 60.79%
66,127 $3.09 Million
Q2 2020

Aug 13, 2020
BUY
$42.56 - $54.98 $1.95 Million - $2.52 Million
45,750 Added 37.22%
168,658 $8.56 Million
Q1 2020

May 14, 2020
BUY
$32.37 - $59.36 $3.98 Million - $7.3 Million
122,908 New
122,908 $5.48 Million

Others Institutions Holding PTCT

# of Institutions
238
Shares Held
75.8M
Call Options Held
130K
Put Options Held
41.3K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.5B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email